Trial intelligence / Profile preview

Silicone Gel for Retroauricular Scar in Microtia

NCT02518035Phase 4Unknown

Sponsor
Chang Gung Memorial Hospital
Start
Jul 2015
Primary completion
Aug 2018
Countries
1
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Scar width at 6 months. Status: unknown.

Beyond the preview

Go deeper on NCT02518035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02518035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call